摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-({[(4-hydroxyphenyl)carbamoyl]methyl}sulfamoyl)benzoic acid

中文名称
——
中文别名
——
英文名称
2-({[(4-hydroxyphenyl)carbamoyl]methyl}sulfamoyl)benzoic acid
英文别名
SCP-123;SCP-M1;2-{[(4-Hydroxyphenylcarbamoyl)methyl]sulfamoyl}benzoic acid;2-[[2-(4-hydroxyanilino)-2-oxoethyl]sulfamoyl]benzoic acid
2-({[(4-hydroxyphenyl)carbamoyl]methyl}sulfamoyl)benzoic acid化学式
CAS
——
化学式
C15H14N2O6S
mdl
——
分子量
350.352
InChiKey
SORCZKVIGXLCNH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    141
  • 氢给体数:
    4
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-({[(4-hydroxyphenyl)carbamoyl]methyl}sulfamoyl)benzoic acid 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 以99%的产率得到SCP-123ss
    参考文献:
    名称:
    First Multigram Preparation of SCP-123, A Novel Water-Soluble Analgesic
    摘要:
    A short multigram process for the preparation of the analgesic compound SCP-123 (4) and its sodium salt has been developed.
    DOI:
    10.1021/op900113b
  • 作为产物:
    描述:
    SCP-1sodium hydroxide 作用下, 以 为溶剂, 反应 0.33h, 以80%的产率得到2-({[(4-hydroxyphenyl)carbamoyl]methyl}sulfamoyl)benzoic acid
    参考文献:
    名称:
    Analgesic compounds, their synthesis and pharmaceutical compositions containing them
    摘要:
    本发明揭示了一些新的镇痛化合物,这些化合物是通过N-酰化的4-羟基苯胺衍生物的水解制备而成,还揭示了它们的合成方法和包含它们的药物组合物。这些化合物出人意料地具有高度的镇痛活性,且对肝脏毒性影响较小,因此在慢性疼痛的治疗中比传统的非甾体抗炎药(NSAIDs)更加有用。
    公开号:
    US06806291B1
点击查看最新优质反应信息

文献信息

  • Analgesic compounds, their synthesis and pharmaceutical compositions containing them
    申请人:The Foundation for the LSU Health Sciences Center
    公开号:US06806291B1
    公开(公告)日:2004-10-19
    New analgesic compounds, which are prepared by the hydrolysis of N-acylated 4-hydroxyphenylamine derivatives, their synthesis and pharmaceutical compositions containing them are disclosed. These compounds surprisingly possess high analgesic activity with little hepatotoxic effect, making them more useful than conventional non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of chronic pain.
    本发明揭示了一些新的镇痛化合物,这些化合物是通过N-酰化的4-羟基苯胺衍生物的水解制备而成,还揭示了它们的合成方法和包含它们的药物组合物。这些化合物出人意料地具有高度的镇痛活性,且对肝脏毒性影响较小,因此在慢性疼痛的治疗中比传统的非甾体抗炎药(NSAIDs)更加有用。
  • Compositions and methods for ameliorating pain and reducing fever
    申请人:The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    公开号:US11007199B2
    公开(公告)日:2021-05-18
    This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.
    本发明涉及可用于治疗或改善疼痛和发烧的组合物、方法和试剂盒。
  • Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs
    作者:Anthony L. Vaccarino、Dennis Paul、Pranab K. Mukherjee、Elena B. Rodríguez de Turco、Victor L. Marcheselli、Liang Xu、Mark L. Trudell、J.M. Minguez、M.P. Matía、Carlos Sunkel、Julio Alvarez-Builla、Nicolas G. Bazan
    DOI:10.1016/j.bmc.2006.07.054
    日期:2007.3
    A series of acetaminophen (APAP) analogs, 2-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)-N-(4-hydroxyphenyl)alkanecarboxamides, bearing a heterocyclic moiety linked to the p-acylaminophenol fragment, were prepared in a general project to develop APAP analogs with modulated pharmacokinetic profiles. Unexpectedly, the products described maintained the in vivo analgesic profile, while the characteristic hepatotoxicity of APAP was consistently reduced. One of the products, 5a, was studied in vivo in comparison with APAP. Compound 5a displayed an analgesic efficacy comparable to that of APAP. A relatively high acute oral dose of 5a (6 mmol/kg) produced no measurable toxicity, whereas the equimolar dose of APAP increased transaminase activity, depleted hepatic and renal glutathione, and resulted in mortality. In human hepatocytes (HEPG-2) and in human primary cultures of normal liver cells, APAP, but not 5a, was associated with apoptotic cell death, Fas-ligand up-regulation, and CAR (constitutive androstane receptor) activation, contributing to a favorable safety profile of 5a as an orally delivered analgesic. (c) 2006 Elsevier Ltd. All rights reserved.
  • ANALGESIC COMPOUNDS, THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    申请人:Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    公开号:EP1682496B1
    公开(公告)日:2009-04-08
  • COMPOSITIONS AND METHODS FOR AMELIORATING PAIN
    申请人:The Board of Supervisors of Louisiana State University and Agricultural and Mechanical Colleg
    公开号:US20200179393A1
    公开(公告)日:2020-06-11
    This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物